ZNF646 Inhibitors

Disulfiram and cisplatin engage in interactions with metal ions and DNA, respectively. Disulfiram's binding with metal ions can modify the structural integrity of zinc finger domains in proteins like ZNF646, thereby affecting their DNA-binding affinity. Cisplatin, by forming DNA adducts, can hinder transcription factor access to DNA, potentially disrupting ZNF646-DNA interactions essential for its function.

Chloroquine and MG132 target autophagic degradation and the ubiquitin-proteasome system, which are pivotal for protein turnover. By modulating these pathways, these compounds can influence ZNF646 levels indirectly. PD98059, LY294002, and SP600125 are kinase pathway inhibitors that impinge upon cell signaling cascades, which can modulate the activity and stability of transcription factors, potentially impacting ZNF646-regulated gene expression. Curcumin's wide-ranging effect on signaling pathways and transcription factors could extend to the modulation of ZNF646 function, given its pleiotropic nature. Lastly, alpha-amanitin inhibits RNA polymerase II, which is responsible for transcribing mRNA. By suppressing mRNA synthesis, alpha-amanitin can affect the transcriptional engagement of ZNF646 with its target genes.